# The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria

> **NCT00674596** · PHASE4 · COMPLETED · sponsor: **Gulhane School of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes
- Proteinuria
- Renin Angiotensin System

## Interventions

- **DRUG:** ramipril

## Key facts

- **NCT ID:** NCT00674596
- **Lead sponsor:** Gulhane School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00674596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00674596, "The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00674596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*